Table 3.
2014 Cohort | 2016 Cohort | |||
---|---|---|---|---|
Variable | Odds Ratio (95% CI) | P Value | Odds Ratio (95% CI) | P Value |
VRE colonization | 1.58 (0.92–2.62) | .08 | 2.07 (1.06–3.83) | .03 |
Male gender | 0.7 (0.51–0.96) | .03 | 1.14 (0.71–1.85) | .6 |
Race (ref. white) | ||||
Black | 1.38 (0.85–2.2) | .18 | 1.91 (0.94–3.63) | .06 |
Other | 0.71 (0.27–1.59) | .45 | 1.29 (0.3–3.88) | .68 |
Unknown | 1.13 (0.44–2.55) | .78 | 2.94 (0.44–11.63) | .17 |
Days in hospital | 0.99 (0.98–1) | .22 | 1 (0.98–1.01) | .6 |
Albumin ≤3 | 0.95 (0.69–1.31) | .77 | 0.87 (0.47–1.53) | .64 |
Age (ref. <50 y) | ||||
50–60 y | 1.66 (1.04–2.66) | .03 | 0.84 (0.37–1.84) | .66 |
60–70 y | 1.72 (1.1–2.71) | .02 | 1.17 (0.6–2.31) | .65 |
Over 70 y | 1.73 (1.09–2.78) | .02 | 1.8 (0.96–3.47) | .07 |
Death within 30 d | 1.25 (0.74–2.05) | .39 | 1.68 (0.85–3.15) | .12 |
Neurologic disorder | 1.07 (0.58–1.88) | .81 | 2.07 (0.9–4.4) | .07 |
Pulmonary circulation disorder | 0.96 (0.47–1.82) | .91 | 2.18 (0.95–4.57) | .05 |
Hypertension | 1.33 (0.97–1.83) | .08 | 0.49 (0.22–0.97) | .05 |
Abbreviations: CI, confidence interval; VRE, vancomycin-resistant Enterococci.